More Healthcare, IT and Consumption names are expected to be included in the HSI
■ Hang Seng Indexes Company Limited (HSIC) will announce the results of its 3Q21 review of the Hang Seng Family of Indexes after market close on 19 Nov 2021. The changes will be effective on 6 Dec 2021.
■ At least three names are expected to be added to the Hang Seng Index to achieve the target of 80 constituents by mid-2022.
■ In terms of market cap and trading liquidity, potential candidates include Kuaishou [1024.HK], JD Health [6618.HK], Baidu [9888.HK], NetEase [9999.HK], Smoore [6969.HK], Beigene [6160.HK], Nongfu Spring [9633.HK], JD Logisitcs [2618.HK],
JD.com [9618.HK], CR Beer [0291.HK], Hansoh Pharma [3692.HK], Li Auto [2015.HK], China Feihe [6186.HK], ENN Energy [2688.HK], SMIC [0981.HK] and BiliBili [9626.HK].
■ According to a previous study by HSIC, Consumption, Healthcare and Properties & Construction are under-represented. Consumption and Healthcare may also have a high possibility of being added to the Hang Seng Index.
■ The weighting of larger-cap names such as Meituan [3690.HK] and Tencent [0700.HK] may be reduced because of the 8% cap.